止咳药的全球市场调查报告-产业分析，规模，占有率，成长，趋势，2022年～2028年前的预测

Value Market Research深入调查止咳药的全球市场，并预测未来几年行业将出现显着增长。本研究报告提供全球止咳药市场相关之完全产业分析，提供市场规模、市场占有率、增长趋势、2023年至2028年的预测等。该报告以详细的市场介绍和突出报告关键增长数据的执行摘要为首。接续的章节讨论市场价值链、波特五力模型和市场吸引力分析。同时还设立关于COVID-19影响分析的独立章节，以了解市场如何应对疫情。

本报告的市场动态部分详细介绍了当前的市场推动因素/阻碍、课题/风险和未来机遇。本节对企业战略家和新产品开发部门非常有用。止咳药全球市场调查将市场细分化，并根据收益和/或销售额的视点提供市场规模。该数据地区细分，同时国家/地区细分。数据是通过深入的初级访谈和世界各地的行业专家收集而来。详细的调查方法可以在样本报告中找到。这些市场预测受到最新的社会、政治和经济变化以及影响该止咳药市场的当前市场动态所影响。

止咳药市场报告的子章节提供市场竞争力调查，提供一些领先的市场参与者/製造商简介。这些章节涵括可深入了解竞争对手的产品线、财务状况、最新发展以及在行业中拥有最高市场占有率公司所需的丰富资讯。

本报告的观察对象国家如下列。

北美:美国，加拿大，墨西哥

欧洲:英国，德国，法国，义大利，俄罗斯，西班牙，其他的欧洲地区

亚太地区:中国，印度，日本，韩国，澳洲，其他APAC的各国

南美:巴西，阿根廷，秘鲁，智利及其他的南美各国

中东·非洲地区:沙乌地阿拉伯，UAE，以色列，南非

本报告的市场区隔如下列。

各药物类别

中枢性药物(类鸦片物质，非类鸦片物质)

末梢性药物(吩诺二秦，其他)

其他

各给药途径

口服

吸入

其他

各终端用户

医院

专门诊所

其他

各销售管道

医院药局

零售药局

其他

目录

第1章 序文

• 本报告的内容
  • 目的
  • 主要读者
  • 独特的销售主张(USP)及提供服务
• 调查范围
• 调查手法
  • 市场调查流程
  • 市场调查手法

第2章 摘要整理

• 市场概况
• 全球市场概述

第3章 止咳药:产业分析

• 简介- 市场动态
• 推动市场要素
• 阻碍市场要素
• 商机
• 产业趋势
• 波特的五力分析
• 市场魅力分析
  • 各药物类别
  • 各给药途径
  • 各终端用户
  • 各流通管道
  • 各地区

第4章 价值链分析

• 价值链分析
• 原料的分析
  • 原料的清单
  • 原料的製造原清单
  • 主要原料的价格趋势
• 潜在的买主清单
• 销售管道
  • 直销
  • 间接行销
  • 行销流通管道的新兴国家市场开拓趋势

第5章 COVID-19发生的影响分析

• COVID-19发生影响分析
  • 对生产的直接性影响
  • 供应链与市场的混乱
  • 对企业及金融市场的财务的影响
• COVID-19生产，进口，出口，各需求的影响分析
• 市场COVID-19发生前/发生后
• 冠状病毒(COVID-19)流行的影响预测
• COVID-19:微观和宏观的要素分析

第6章 止咳药的全球市场分析:各药物类别

• 各药物类别概要
• 实际成果资料与预测资料
• 各药物类别分析
• 中枢性药物(类鸦片物质，非类鸦片物质)各地区市场转变
• 末梢性促效剂(吩诺二秦，其他)各地区市场转变
• 其他各地区市场

第7章 止咳药的全球市场分析:各给药途径

• 各给药途径概要
• 实际成果资料与预测资料
• 各给药途径分析
• 各地区口服给药市场
• 吸入给药的各地区市场
• 其他的各地区市场

第8章 止咳药的全球市场分析:各终端用户

• 各终端用户概要
• 实际成果资料与预测资料
• 各终端用户分析
• 医院市场各地区转变
• 专门诊所的各地区市场
• 其他各地区市场

第9章 止咳药的全球市场分析:各流通管道

• 各流通管道概要
• 实际成果资料与预测资料
• 各流通管道分析
• 医院药局的各地区市场
• 零售药局的各地区市场
• 其他各地区市场

第10章 止咳药的全球市场分析:各地区

• 各地区展望
• 简介
• 北美
  • 概要，过去实际成果与预测资料
  • 北美:各市场区隔
  • 北美各国资料
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 概要，过去实际成果与预测资料
  • 欧洲:各市场区隔
  • 欧洲的各国资料
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他的欧洲地区
• 亚太地区
  • 概要，过去实际成果与预测资料
  • 亚太地区:各市场区隔
  • 亚太地区各国资料
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 其他亚太地区
• 南美
  • 概要，过去实际成果与预测资料
  • 南美:各市场区隔
  • 南美:各国资料
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他的南美地区
• 中东·非洲地区
  • 概要，过去实际成果与预测资料
  • 中东·非洲:各市场区隔
  • 中东·非洲地区各国资料
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他的中东·非洲地区

第11章 止咳药企业的竞争情形

• 止咳药的市场竞争
• 联盟·合作·协定
• 合併·收购
• 新产品上市
• 其他的开发

第12章 企业简介

• 企业占有率分析
• 市场集中度
• Toray Industries
  • 企业概要
  • 产品介绍
  • 最近的开发情形
• Zoetus
  • 公司概要
  • 产品介绍
  • 最近的开发情形
• Pfizer
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Novartis AG
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Merck & Co.
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Sanofi
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Glenmark Pharmaceuticals
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Alkem Laboratories
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Zydus Cadila
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• AstraZeneca
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Cipla
  • 公司概要
  • 产品资讯
  • 最近的开发情形
• Johnson & Johnson
  • 公司概要
  • 产品资讯
  • 最新资讯

在公司简介中，财务细节和最近的发展基于可取得的现有信息，可能不包含非上市公司。

Value Market Research deeply researched the Global Antitussive Drugs Market to foresee a significant growth in the industry over the upcoming years. The global antitussive drugs market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global antitussive drugs market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this antitussive drugs market.

The next sections of the antitussive drugs market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America: United States, Canada, and Mexico

Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC

Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Drug Class

Centrally Acting Drugs (Opioids and Non-opioids)

Peripherally Acting Drugs (Phenoxdiazine and Others)

Others

By Route of Administration

Oral

Inhalational

Others

By End-Users

Hospitals

Specialty Clinics

Others

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Others

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ANTITUSSIVE DRUGS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 By Drug Class
  • 3.7.2 By Route of Administration
  • 3.7.3 By End-Users
  • 3.7.4 By Distribution Channel
  • 3.7.5 By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

• 5.1. Impact Analysis of Covid-19 Outbreak
  • 5.1.1. Direct Impact on Production
  • 5.1.2. Supply Chain and Market Disruption
  • 5.1.3. Financial Impact on Firms and Financial Markets
• 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
• 5.3. Market: Pre V/S Post COVID-19
• 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
• 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DRUG CLASS

• 6.1 Overview by Drug Class
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Drug Class
• 6.4 Centrally Acting Drugs (Opioids and Non-opioids) Market by Regions
• 6.5 Peripherally Acting Drugs (Phenoxdiazine and Others) Market by Regions
• 6.6 Others Market by Regions

7 . GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

• 7.1 Overview by Route of Administration
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Route of Administration
• 7.4 Oral Market by Regions
• 7.5 Inhalational Market by Regions
• 7.6 Others Market by Regions

8 . GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY END-USERS

• 8.1 Overview by End-Users
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End-Users
• 8.4 Hospitals Market by Regions
• 8.5 Specialty Clinics Market by Regions
• 8.6 Others Market by Regions

9 . GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 9.1 Overview by Distribution Channel
• 9.2 Historical and Forecast Data
• 9.3 Analysis by Distribution Channel
• 9.4 Hospital Pharmacy Market by Regions
• 9.5 Retail Pharmacy Market by Regions
• 9.6 Others Market by Regions

10 . GLOBAL ANTITUSSIVE DRUGS MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America
  • 10.3.1. Overview, Historic and Forecast Data
  • 10.3.2. North America By Segment
  • 10.3.3. North America By Country
  • 10.3.4. United State
  • 10.3.5. Canada
  • 10.3.6. Mexico
• 10.4. Europe
  • 10.4.1. Overview, Historic and Forecast Data
  • 10.4.2. Europe by Segment
  • 10.4.3. Europe by Country
  • 10.4.4. United Kingdom
  • 10.4.5. France
  • 10.4.6. Germany
  • 10.4.7. Italy
  • 10.4.8. Russia
  • 10.4.9. Rest Of Europe
• 10.5. Asia Pacific
  • 10.5.1. Overview, Historic and Forecast Data
  • 10.5.2. Asia Pacific by Segment
  • 10.5.3. Asia Pacific by Country
  • 10.5.4. China
  • 10.5.5. India
  • 10.5.6. Japan
  • 10.5.7. South Korea
  • 10.5.8. Australia
  • 10.5.9. Rest Of Asia Pacific
• 10.6. Latin America
  • 10.6.1. Overview, Historic and Forecast Data
  • 10.6.2. Latin America by Segment
  • 10.6.3. Latin America by Country
  • 10.6.4. Brazil
  • 10.6.5. Argentina
  • 10.6.6. Peru
  • 10.6.7. Chile
  • 10.6.8. Rest of Latin America
• 10.7. Middle East & Africa
  • 10.7.1. Overview, Historic and Forecast Data
  • 10.7.2. Middle East & Africa by Segment
  • 10.7.3. Middle East & Africa by Country
  • 10.7.4. Saudi Arabia
  • 10.7.5. UAE
  • 10.7.6. Israel
  • 10.7.7. South Africa
  • 10.7.8. Rest Of Middle East And Africa

11 . COMPETITIVE LANDSCAPE OF THE ANTITUSSIVE DRUGS COMPANIES

• 11.1. Antitussive Drugs Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12 . COMPANY PROFILES OF ANTITUSSIVE DRUGS INDUSTRY

• 12.1. Company Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Toray Industries
  • 12.3.1. Company Overview
  • 12.3.2. Financials
  • 12.3.3. Products
  • 12.3.4. Recent Developments
• 12.4. Zoetus
  • 12.4.1. Company Overview
  • 12.4.2. Financials
  • 12.4.3. Products
  • 12.4.4. Recent Developments
• 12.5. Pfizer
  • 12.5.1. Company Overview
  • 12.5.2. Financials
  • 12.5.3. Products
  • 12.5.4. Recent Developments
• 12.6. Novartis AG
  • 12.6.1. Company Overview
  • 12.6.2. Financials
  • 12.6.3. Products
  • 12.6.4. Recent Developments
• 12.7. Merck & Co.
  • 12.7.1. Company Overview
  • 12.7.2. Financials
  • 12.7.3. Products
  • 12.7.4. Recent Developments
• 12.8. Sanofi
  • 12.8.1. Company Overview
  • 12.8.2. Financials
  • 12.8.3. Products
  • 12.8.4. Recent Developments
• 12.9. Glenmark Pharmaceuticals
  • 12.9.1. Company Overview
  • 12.9.2. Financials
  • 12.9.3. Products
  • 12.9.4. Recent Developments
• 12.10. Alkem Laboratories
  • 12.10.1. Company Overview
  • 12.10.2. Financials
  • 12.10.3. Products
  • 12.10.4. Recent Developments
• 12.11. Zydus Cadila
  • 12.11.1. Company Overview
  • 12.11.2. Financials
  • 12.11.3. Products
  • 12.11.4. Recent Developments
• 12.12. AstraZeneca
  • 12.12.1. Company Overview
  • 12.12.2. Financials
  • 12.12.3. Products
  • 12.12.4. Recent Developments
• 12.13. Cipla
  • 12.13.1. Company Overview
  • 12.13.2. Financials
  • 12.13.3. Products
  • 12.13.4. Recent Developments
• 12.14. Johnson & Johnson
  • 12.14.1. Company Overview
  • 12.14.2. Financials
  • 12.14.3. Products
  • 12.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• COVID-19 Impact Analysis by Production, Import, Export and Demand
• Pre V/S Post COVID-19
• Estimated Impact Of The Coronavirus (Covid-19) Epidemic
• COVID-19: Micro and Macro Factor Analysis
• Analysis by Drug Class (USD MN)
• Centrally Acting Drugs (Opioids and Non-opioids) Market by Geography (USD MN)
• Peripherally Acting Drugs (Phenoxdiazine and Others) Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Analysis Market by Route of Administration (USD MN)
• Oral Market by Geography (USD MN)
• Inhalational Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Analysis by End-Users (USD MN)
• Hospitals Market by Geography (USD MN)
• Specialty Clinics Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Analysis by Distribution Channel (USD MN)
• Hospital Pharmacy Market by Geography (USD MN)
• Retail Pharmacy Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Antitussive Drugs Market by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisiton

LIST OF FIGURES

• Research Scope of Antitussive Drugs Report
• Market Research Process
• Market Research Methodology
• Global Antitussive Drugs Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Drug Class
• Market Attractiveness Analysis by Route of Administration
• Market Attractiveness Analysis by End-Users
• Market Attractiveness Analysis by Distribution Channel
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Drug Class (USD MN)
• Centrally Acting Drugs (Opioids and Non-opioids) Market by Geography (USD MN)
• Peripherally Acting Drugs (Phenoxdiazine and Others) Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market Analysis by Route of Administration (USD MN)
• Oral Market by Geography (USD MN)
• Inhalational Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market Analysis by End-Users (USD MN)
• Hospitals Market by Geography (USD MN)
• Specialty Clinics Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market Analysis by Distribution Channel (USD MN)
• Hospital Pharmacy Market by Geography (USD MN)
• Retail Pharmacy Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.